D Blunt - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

D Blunt

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2016

The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic LeukemiaMatthew D Blunt, Stefan Koehrer, Rachel C Dobson, et al.

Immunotherapy Advances|September 22, 2025

CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axisLara V Graham, Ludmila Horehajova, Marco V Haselager, et al.

Leukemia|August 30, 2019

BCR signaling contributes to autophagy regulation in chronic lymphocytic leukemiaLindsay D Smith, Annabel R Minton, Matthew D Blunt, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2016

The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic LeukemiaMatthew D Blunt, Stefan Koehrer, Rachel C Dobson, et al.

Immunotherapy Advances|September 22, 2025

CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axisLara V Graham, Ludmila Horehajova, Marco V Haselager, et al.

Leukemia|August 30, 2019

BCR signaling contributes to autophagy regulation in chronic lymphocytic leukemiaLindsay D Smith, Annabel R Minton, Matthew D Blunt, et al.

Pageof 6